Alzheimer’s Disease Diagnostic Market: Blood-Based...

bir ses eklendi Wellness

2026-11-10 06:14:37 - Translate -

Alzheimer’s Disease Diagnostic Market: Blood-Based Biomarkers, Amyloid PET Imaging, and Early Neuro-degeneration Screening Driving Growth

Surging global prevalence of neurodegenerative disorders, expanding clinical availability of disease-modifying anti-amyloid therapies, and continuous technological refinements in high-sensitivity immunoassay platforms are driving rapid growth across the global Alzheimer’s Disease Diagnostic Market. Alzheimer's disease diagnostic tools—comprising blood-based biomarker assays (such as...

0 Yorumlar 0 hisse senetleri 5 Views 0 önizleme